Introduction {#s1}
============

HIV testing and counseling (HTC) is the cornerstone of HIV prevention, care, and treatment. Knowledge of HIV status among HIV-infected persons is associated with a 60% reduction in transmission risk behavior [@pone.0036797-Crepaz1], [@pone.0036797-Bunnell1]. HTC is an essential component of behavioral interventions [@pone.0036797-Allen1]--[@pone.0036797-Denison1] and for targeting specific populations such as HIV discordant couples [@pone.0036797-Matovu1], children [@pone.0036797-Kellerman1] or patients with sexually transmitted infections (STI) [@pone.0036797-Kamb1]. HTC is a necessary prerequisite to accessing life-extending care and antiretroviral treatment for persons with HIV infection. Antiretroviral therapy for people with HIV has been associated with a 96% reduction in HIV transmission in discordant couples [@pone.0036797-Cohen1], universal HIV testing and immediate antiretroviral treatment has been suggested as a strategy to control generalized HIV epidemics [@pone.0036797-Granich1] and would also have a major effect on the HIV-associated tuberculosis epidemic [@pone.0036797-Harries1].

In spite of HTC\'s central role in HIV programming, HIV testing coverage remains low in sub-Saharan Africa. Testing coverage documented in population-based surveys in sub-Saharan Africa 2007--2008 ranged from 3.2% in women and 4.9% in men in Liberia to 56.7% in women and 43.0% in men in South Africa [@pone.0036797-WHOUNAIDS1]. Barriers to HTC vary by setting and stage of the epidemic, but have included low perceived risk [@pone.0036797-Nakanjako1], stigma and fear of discrimination [@pone.0036797-Kalichman1], concerns of confidentiality [@pone.0036797-Creek1], lack of access to free testing [@pone.0036797-Nakanjako1], cost of transportation [@pone.0036797-Wanyenze1], negative perception of testing services [@pone.0036797-Kalichman1], shortage of counselors [@pone.0036797-Creek1] and delays in returning testing results [@pone.0036797-Creek1].

Kenya has scaled up HTC capacity significantly since 2003, including traditional voluntary counseling and testing sites, mobile, provider-initiated [@pone.0036797-Marum1] and, more recently, door-to-door HTC [@pone.0036797-Negin1]. The Kenya AIDS Indicator Survey (KAIS) 2007 was the first nationally representative survey in Kenya that measured laboratory testing results for HIV, herpes simplex virus type 2 (HSV-2), syphilis, and CD4 counts for HIV-infected respondents, and interview data on demographics, sexual behaviors, and service utilization including prior testing history and current HIV status. To improve HTC program planning and delivery, we analyzed KAIS data to compare laboratory testing with self-reported HIV results to determine the prevalence of correct knowledge of HIV status in the country, to identify characteristics of persons aged 15--64 years who had never tested for HIV, and to identify missed opportunities for HIV testing.

Methods {#s2}
=======

Study design {#s2a}
------------

KAIS was a nationally representative, cross-sectional, household sero-survey of persons aged 15 to 64 years conducted from August to December 2007. The survey used a two-stage, stratified sampling design to provide national estimates and separate estimates for urban and rural areas and for each of the eight provinces. The design was comparable with the design of the 2003 Kenya Demographic and Health Survey (DHS), which also included basic questions on HTC. The first stage involved selecting clusters from the same sampling frame that was used for the 2003 DHS, based on the 1999 national census, and the second stage involved the selection of households per cluster with equal probability of selection in the rural-urban strata within each district. Fieldwork was conducted by 29 field teams, each consisting of six data collectors (four interviewers and two laboratory technicians), one supervisor and one driver. Interviewers and laboratory technicians were provided by the Kenya National Bureau of Statistics and the National AIDS/STI Control Programme, respectively. In addition to questionnaires in Kiswahili and English, teams administered questionnaires in local languages where necessary to accommodate respondents that were not conversant in vernacular languages. All questionnaires were back translated into English. Survey personnel participated in intensive two-week training in KAIS procedures, including finger stick, specimen collection for HIV testing and HIV education and counseling. All participants had the option to receive their results individually or as a couple at a nearby referral site [@pone.0036797-NASCOP1]. Demographic and HIV/AIDS-specific indicators included use of HIV testing services, HIV status, pregnancy status in women, male circumcision, perception of HIV risk, history of sexually transmitted infections, sexual risk behaviors, and use of in- and outpatient services. Participants were asked 'Have you ever been tested to see if you have the virus that causes AIDS?' and if they responded 'yes' then the interviewer continued asking 'When was the last time you were tested?', 'Did you get the result of that test?', and if the participant confirmed that he/she had received the result he/she was asked 'Would you be willing to share with me the result of your (last) HIV test?' and 'Did the test show that you had the HIV virus?' Further details of KAIS methods are available elsewhere [@pone.0036797-NASCOP1].

Laboratory methods {#s2b}
------------------

Blood specimens obtained in households were tested at Kenya\'s national reference laboratory in Nairobi for HIV, HSV-2, syphilis and CD4 count for HIV-infected persons. HIV testing was performed in a serial testing algorithm by using Vironostika HIV Uni-Form II antigen/antibody (BioMérieux Bv, Boseind, Netherlands) and Murex HIV antigen/antibody (Abbott/Murex-Biotech Ltd, Kent, UK) tests for HIV screening and confirmation, respectively. HIV discrepant specimens were retested with the two assays and polymerase chain reaction (PCR) (Roche HIV DNA v 1.5) tests were conducted on all samples with two sets of discrepant results. For quality control, all positive specimens and a random sample of 5% of negative specimens were retested in a different laboratory using the same testing algorithm. The Kalon HSV Type 2- specific IgG EIA was used for HSV-2 testing. This was a recombinant type-2 antigen (gG2) modified to eliminate reactivity arising from HSV type 1 infection and at the same time retaining the natural antigenic characteristics of HSV-2. For syphilis testing, the *Treponema pallidum* particle agglutination (TPPA) assay was used as a screening test and rapid plasma reagin (RPR) for confirmation.

Measures {#s2c}
--------

Correct knowledge of HIV status was defined as reported HIV status validated by laboratory testing during the survey. Ever testing was defined as self-report of one or more HIV tests prior to the survey. We developed gender-specific models to assess factors associated with ever having been tested for HIV in ever sexually active persons. Predictor variables included socio-demographic characteristics, pregnancy history and status, HSV-2 infection, syphilis infection, perception of HIV risk, lifetime sexual partners, condom use at last sex, number of outpatient visits in the last 12 months, number of hospitalizations in the last 12 months (excluding outpatient or antenatal care visits), and male circumcision status. We reported predictors for men and women separately because of differences in testing rates. Wealth was defined using a DHS standard composite index of the living standard of a household, calculated using data on a household\'s ownership of selected assets, materials used for housing construction, water access and sanitation facilities [@pone.0036797-Rutstein1]. The wealth index placed households on a continuous scale of relative wealth using principal components analysis. Individuals were categorized according to the score of their household and the sample was divided into quintiles, each with an equal number of individuals, ranging from the poorest to wealthiest.

Statistical analysis {#s2d}
--------------------

We performed all analyses in SAS version 9.2 (SAS Institute Inc., Cary, North Carolina, USA) using the sample survey procedures to take into account the sampling structure (stratification, sample weighting, and clustering), and with appropriate domain analysis for each subpopulation of interest. Statistical significance in cross-tabulations was assessed based on Rao-Scott chi-square p-values. The p-value for the difference between CD4 cell counts was calculated using linear regression (PROC SURVEYREG) on log-transformed CD4 counts. Using multivariable logistic regression (PROC SURVEYLOGISTIC), we calculated adjusted odds ratios (AOR) and 95% confidence intervals (CI) to identify variables independently associated with the outcome. Analyses accounted for the stratified cluster design of the survey. Each response was weighted to account for its sampling probability and to adjust for non-response rates. Variables with a p-value \<0.1 in bivariate analyses were selected for final multivariable models and backwards elimination was used if they did not remain significant at a 0.05 p-value level. The category with the strongest association was defined as the maximum negative or positive difference from the reference 1. Two-way interactions between variables were considered. Population estimates were calculated based on the 2007 projected Kenyan population [@pone.0036797-KNBS1]. The gap between Kenya\'s national testing target and testing coverage documented in KAIS was calculated by subtracting 2007 testing rates from Kenya\'s national target of 80% of the sexually active population to know their HIV status [@pone.0036797-NASCOP2] and multiplying with the projected base population. Uncertainty bounds were calculated by multiplying lower and upper confidence limits, respectively, from KAIS estimates for sexual activity and HIV testing.

Ethics statement {#s2e}
----------------

Oral informed consent was obtained from all eligible persons in a three-stage-process: 1) to be interviewed, 2) to have a blood specimen drawn, and 3) to have their blood stored without identifiers for possible future tests. For each of the components, the interviewer signed the consent form to indicate whether or not consent was given. For participants aged 15--17 years, parental or guardian permission was obtained. Eligible persons aged 15--17 years were then asked for their assent. Mature minors, operationalized in KAIS as persons who were married, pregnant or parents, or who were guardians of children aged 0--4 years whose mother died or was HIV infected, did not need parental consent [@pone.0036797-NASCOP3]. Investigators obtained a waiver of documentation of informed consent for all participants because the research presented no more than minimal risk of harm to the subjects, the waiver did not adversely affect the rights and welfare of the participants, and the survey involved no procedures for which written consent is normally required outside the research context in Kenya. Survey protocols, including consent procedures, were approved by the Ethics Review Committee of the Kenya Medical Research Institute (KEMRI) and the Institutional Review Board of the U.S. Centers for Disease Control and Prevention (CDC).

Results {#s3}
=======

A total of 15,853 of 19,840 eligible persons aged 15--64 years participated in interviews and blood specimen collection, representing a response rate of 80% (women 83%, men 77%). Among those, 1104 or 7.1% (95% CI 6.5--7.7) were HIV infected (men 5.4%, 95% CI 4.7--6.0; women: 8.4%, 95% CI 7.5--9.2). HIV prevalence ranged between 0.8% (95% CI 0--1.6) in North-Eastern to 8.8% (95% CI 6.3--11.4) in Nairobi and 14.9% (95% CI 13.1--16.6) in Nyanza province. Among participants in interviews and blood draws, 87.8% (95% CI 87.1--88.5) reported that they had ever been sexually active (men 85.9%, 95% CI 84.7--87.2; women 89.2%, 95% CI 88.4--90.0). Among those ever sexually active, 27.4% (95% CI 25.6--29.2) of men and 44.2% (95% CI 42.5--46.0) of women reported that they had ever tested for HIV. The gap between Kenya\'s national testing target and testing coverage documented in KAIS in 2007 was an estimated 4,366,000 (uncertainty bounds 4,280,000--4,452,000) men aged 15--64 years old and 3,295,000 (uncertainty bounds 3,157,000--3,421,000) women.

Predictors of HIV testing {#s3a}
-------------------------

There were no significant differences between HIV-infected and HIV-uninfected persons regarding HIV testing history. Highest ever HIV testing rates in men were found for age 30--34 years, urban residence, Nairobi province, secondary or higher education, highest wealth index quintile and contact with health facilities. Women who had had an HIV test had similar characteristics as men, but had a highest testing rate at age 20--24 ([Table 1](#pone-0036797-t001){ref-type="table"}). HIV testing rates were significantly higher among women of reproductive age (15--49 years) (49.4%, 95% CI 47.5--51.2) compared to men in the same age group (28.9%, 95% CI 27.1--30.7, p\<0.0001). Among women aged 15--49 years who reported ever having sex, 33.5% (95% CI 31.8--35.3) had never been tested for HIV, 48.7% (95% CI 46.8--50.6) had their last HIV test during antenatal care, and an additional 17.7% (95% CI 16.3--19.1) had their last HIV test elsewhere. Among women 15--49 who had ever been tested for HIV, 66.1% (63.6--68.6) had their last HIV test as part of routine antenatal care (ANC). Among older adults (aged 50--64 years), HIV testing was significantly lower overall and higher in men (20.8%, 95% CI 17.7--23.9) compared to women (13.6%, 95% CI 11.0--16.1, p\<0.0001).

10.1371/journal.pone.0036797.t001

###### Socio-demographic characteristics of persons aged 15--64 years reporting ever HIV testing, by gender, Kenya AIDS Indicator Survey 2007.

![](pone.0036797.t001){#pone-0036797-t001-1}

                                                           Male   Female                                           
  ------------------------------------------------------- ------ -------- ------ ------------ ------ ------ ------ ------------
  **Characteristics**                                                                                              
  **Total**                                                5824    1622    27.4   25.6--29.2   7841   3466   44.2   42.5--46.0
  **Age**                                                                                                          
  15--19                                                   507      84     16.4   12.3--20.4   576    258    45.0   40.5--49.5
  20--24                                                   867     290     32.5   29.2--35.9   1385   903    66.8   63.4--70.2
  25--29                                                   818     285     32.7   28.4--37.0   1277   768    61.5   57.9--65.1
  30--34                                                   753     265     35.6   31.1--40.1   1107   592    52.4   48.2--56.7
  35--39                                                   666     207     30.4   25.7--35.1   923    401    41.8   37.9--45.6
  40--44                                                   567     148     26.3   22.1--30.5   718    235    30.9   26.2--35.5
  45--49                                                   539     127     21.2   17.3--25.0   708    158    20.9   17.3--24.5
  50--54                                                   415      98     24.2   19.6--28.9   500     81    16.7   12.9--20.5
  55--59                                                   373      70     19.1   13.8--24.4   414     56    15.0   9.8--20.3
  60--64                                                   319      48     18.6   11.8--25.3   233     14    5.4     2.3--8.5
  **Residence**                                                                                                    
  Urban                                                    1535    652     42.1   38.7--45.6   1983   1209   60.5   56.3--64.8
  Rural                                                    4289    970     23.0   21.1--25.0   5858   2257   39.0   37.0--41.0
  **Region**                                                                                                       
  Nairobi                                                  724     362     47.1   42.9--51.3   901    606    68.5   64.1--73.0
  Central                                                  860     229     26.7   23.4--30.0   1120   516    46.5   42.9--50.0
  Coast                                                    695     198     31.1   25.6--36.7   935    461    50.1   45.1--55.0
  Eastern                                                  917     183     19.4   16.6--22.3   1291   456    36.0   33.2--38.7
  North Eastern                                            185      14     6.1    0.4--11.7    235     26    9.3    2.2--16.3
  Nyanza                                                   857     255     31.8   27.6--35.9   1231   513    43.6   39.1--47.7
  Rift                                                     863     210     24.8   19.2--30.3   1123   453    39.0   34.1--44.0
  Western                                                  723     171     23.7   19.8--27.7   1005   435    43.6   39.1--48.0
  **Marital Status**                                                                                               
  Currently married/cohabitating                           3899    1088    28.1   25.8--30.3   5492   2498   45.6   43.4--47.7
  Never married/cohabitating                               1557    433     26.0   23.5--28.6   1085   493    44.1   40.7--47.5
  Divorced/separated                                       281      73     25.9   20.2--31.5   594    282    50.4   45.2--55.6
  Widowed                                                   87      28     28.3   17.0--39.6   670    193    28.7   24.6--32.9
  **Education**                                                                                                    
  No education                                             471      30     7.2    3.7--10.6    1347   262    20.1   16.9--23.3
  Incomplete primary                                       1473    269     18.1   15.3--20.9   2237   904    39.1   36.3--41.9
  Complete Primary                                         1525    391     26.1   23.5--28.8   2033   1019   50.3   47.6--53.0
  Secondary or more                                        2355    932     37.7   35.4--40.0   2224   1281   56.4   53.6--59.1
  **Wealth Index**                                                                                                 
  Lowest-fourth                                            4231    914     21.9   20.2--23.5   5869   2269   38.8   36.8--40.8
  Highest                                                  1593    708     43.2   39.7--46.7   1972   1197   59.7   57.0--62.4
  **Ever pregnant**                                                                                                
  No                                                                                           832    325    38.9   34.9--42.9
  Yes                                                                                          7009   3141   44.8   42.9--46.7
  **Currently pregnant**                                                                                           
  No                                                                                           6079   2973   48.4   46.5--50.3
  Yes                                                                                          508    298    60.6   55.6--65.6
  **Male circumcision**                                                                                            
  No                                                       776     236     30.0   25.7--34.3                       
  Yes                                                      5033    1384    27.0   25.2--28.9                       
  **Syphilis infection**                                                                                           
  No                                                       5656    1571    27.4   25.6--29.2   7615   3361   44.3   42.5--46.0
  Yes                                                      117      35     28.5   19.2--37.8   137     55    37.9   27.1--48.6
  **HSV-2 infection**                                                                                              
  No                                                       4118    1090    26.2   24.3--28.2   4230   1914   46.3   44.3--48.4
  Yes                                                      1663    520     30.4   27.7--33.2   3531   1508   41.6   39.3--44.0
  **Perceived HIV risk**                                                                                           
  None                                                     1464    393     28.4   25.0--31.7   1457   717    52.0   48.4--55.7
  Low                                                      2508    750     28.6   26.0--31.1   2541   1204   46.6   43.5--49.7
  Moderate                                                 576     159     28.8   23.7--33.9   1040   486    45.4   41.5--49.3
  Great                                                    228      74     31.1   24.2--38.0   573    280    49.1   43.7--54.4
  **Lifetime sexual partners**                                                                                     
  1                                                        776     174     23.9   19.8--28.0   3141   1303   42.7   40.2--45.1
  2--3                                                     2869    813     28.1   25.9--30.3   4310   2011   46.1   44.1--48.1
  4 or more                                                1806    528     28.0   25.1--31.0   262    104    35.3   28.4--42.2
  **Condom use at last sex**                                                                                       
  No                                                       3018    424     14.9   12.9--16.9   4533   1670   37.0   35.0--39.1
  Yes                                                      645     161     25.1   21.1--29.2   359    146    45.3   38.7--51.9
  **Number of outpatient visits in the last 12 months**                                                            
  0                                                        5029    1345    26.4   24.6--28.1   6454   2878   45.0   43.1--46.8
  1 or more                                                775     271     33.7   29.4--37.9   1360   581    41.2   37.5--45.0
  **Number of hospitalizations in the last 12 months**                                                             
  0                                                        5761    1591    27.2   25.5--29.0   7653   3348   43.7   42.0--45.5
  1 or more                                                 63      31     44.6   31.0--58.2   188    118    63.7   55.5--71.9

Sample size varies slightly across variables due to missing data.

Among ever sexually active adults aged 15--64 years who had never been tested for HIV, 39.6% (95% CI 37.2--41.9) of women and 48.9% (95% CI 46.7--51.1) of men reported they had not been tested because they perceived themselves to be at low risk for HIV infection; 26.7% (95% CI 24.2--29.2) of women and 20.7% (95% CI 18.8--22.5) of men provided no reason for never having been tested. Less than 10% of ever sexually active respondents reported lack of access to testing, fear of others knowing about the test result, not knowing where to go to get tested or lack of access to treatment as reasons for not getting tested.

[Table 2](#pone-0036797-t002){ref-type="table"} presents results of bivariate and multivariable analyses for variables associated with ever HIV testing in separate models of ever sexually active men and women aged 15--64 years. In final multivariable models, independent factors for testing in men included older age, with a strong association when comparing 25--34 year olds and 15--19 year olds (adjusted odds ratio \[AOR\] 2.7, 95% CI: 1.6--4.5; p = 0.0002), province with the strongest association North-Eastern versus Nairobi (AOR 0.2, 95% CI: 0.1--0.7; p = 0.0102), education with the strongest association secondary or more versus no primary education (AOR 4.4, 95% CI: 2.2--8.9; p\<0.0001), highest wealth index versus the four lower categories combined (AOR 1.8, 95% CI: 1.3--2.5; p = 0.0006), condom use at last sex (AOR 1.6, 95% CI: 1.2--2.2; p = 0.0005) and 1 or more versus 0 outpatient visits in the last 12 months (AOR 1.9, 95% CI: 1.4--2.5; p\<0.0001). Independent factors for HIV testing in women included age with the strongest association age 35 and older versus 15--19 years (AOR 0.2, 95% CI: 0.1--0.3; p\<0.0001), urban versus rural (AOR 1.6, 95% CI: 1.2--2.0; p = 0.0005), province with the strongest association North-Eastern versus Nairobi (AOR 0.1, 95% CI: 0--0.3; p\<0.0001, marital status with the strongest association divorced or separated versus never married or cohabitating (AOR 1.9, 95% CI: 1.2--2.9; p = 0.0035), education with the strongest association secondary or more versus no primary education (AOR 3.9, 95% CI: 2.9--5.3; p\<0.0001), ever pregnant (AOR 3.0, 95% CI: 2.2--3.9; p\<0.0001), perceived HIV risk with the strongest associations low versus no perceived risk (AOR 0.7, 95% CI: 0.6--0.9; p = 0.0035) and moderate versus no perceived risk (AOR 0.7, 95% CI: 0.6--0.9; p = 0.0007), and 1 or more versus 0 hospitalizations in the last 12 months (AOR 2.4, 95% CI: 1.6--3.7; p\<0.0001) ([Table 2](#pone-0036797-t002){ref-type="table"}). While adjusted odds for ever HIV testing in men were 2--3 times as high in all age categories 20 years and older compared to men aged 15--19 years, the adjusted odds in women 35 years or older were only one fifth compared to the reference group. There was a trend of increasing AOR for ever HIV testing with higher levels of education in men and women.

10.1371/journal.pone.0036797.t002

###### Unadjusted[\*](#nt102){ref-type="table-fn"} and adjusted odds ratios for factors associated with ever testing for HIV from gender-specific models, Kenya AIDS Indicator Survey 2007.

![](pone.0036797.t002){#pone-0036797-t002-2}

                                                                Male         Female                                                                          
  ------------------------------------------------------- ----------------- --------- ---------------- --------- ---------------- --------- ---------------- ---------
  **Age**                                                                                                                                                    
  15--19                                                      Reference                  Reference                  Reference                  Reference     
  20--24                                                   2.5 (1.8--3.4)    \<.0001   2.2 (1.3--3.6)   0.0023    2.5 (1.9--3.1)   \<.0001   1.4 (1.0--1.9)   0.0423
  25--34                                                   2.6 (1.9--3.6)    \<.0001   2.7 (1.6--4.5)   0.0002    1.6 (1.3--2.0)   \<.0001   0.8 (0.6--1.0)   0.0728
  35 or more                                               1.6 (1.2--2.2)    \<.0001   2.0 (1.2--3.3)   0.0099    0.4 (0.4--0.5)   \<.0001   0.2 (0.1--0.3)   \<.0001
  **Residence**                                                                                                                                              
  Rural                                                       Reference                                             Reference                  Reference     
  Urban                                                    2.4 (2.0--2.9)    \<.0001                              2.4 (2.0--2.9)   \<.0001   1.6 (1.2--2.0)   0.0005
  **Province**                                                                                                                                               
  Nairobi                                                     Reference                  Reference                  Reference                  Reference     
  Central                                                  0.4 (0.3--0.5)    \<.0001   0.7 (0.4--1.0)   0.0767    0.4 (0.3--0.5)   \<.0001   0.7 (0.5--1.0)   0.0587
  Coast                                                    0.5 (0.4--0.7)    \<.0001   1.5 (1.0--2.5)   0.0637    0.5 (0.3--0.6)   \<.0001   1.0 (0.7--1.6)   0.8447
  Eastern                                                  0.3 (0.2--0.3)    \<.0001   0.8 (0.5--1.3)   0.3184    0.3 (0.2--0.3)   \<.0001   0.5 (0.3--0.8)   0.0012
  North Eastern                                             0.1 (0--0.2)     \<.0001   0.2 (0.1--0.7)   0.0102      0 (0--0.1)     \<.0001    0.1 (0--0.3)    \<.0001
  Nyanza                                                   0.5 (0.4--0.7)    \<.0001   1.5 (0.9--2.4)   0.1152    0.4 (0.3--0.5)   \<.0001   0.6 (0.4--0.8)   0.0048
  Rift Valley                                              0.4 (0.3--0.5)    \<.0001   1.1 (0.6--2.0)   0.8310    0.3 (0.2--0.4)   \<.0001   0.5 (0.3--0.8)   0.0013
  Western                                                  0.4 (0.3--0.5)    \<.0001   1.2 (0.7--2.0)   0.5309    0.4 (0.3--0.5)   \<.0001   0.6 (0.4--0.9)   0.0268
  **Marital Status**                                                                                                                                         
  Never married/cohabitating                                                                                        Reference                  Reference     
  Currently married/cohabitating                                                                                  1.1 (0.9--1.2)   0.4800    1.8 (1.3, 2.3)   \<.0001
  Divorced/Separated                                                                                              1.3 (1.0--1.6)   0.0194    1.9 (1.2--2.9)   0.0035
  Widowed                                                                                                         0.5 (0.4--0.6)   \<.0001   2.6 (1.4--4.9)   0.0028
  **Education**                                                                                                                                              
  No primary                                                                             Reference                  Reference                  Reference     
  Incomplete Primary                                       2.9 (1.7--4.7)    \<.0001   2.5 (1.2--5.1)   0.0117    2.5 (2.0--3.2)   \<.0001   2.1 (1.5--2.8)   \<.0001
  Complete Primary                                         4.6 (2.7--7.8)    \<.0001   3.5 (1.7--7.1)   0.0007    4.0 (3.3--4.9)   \<.0001   2.9 (2.1--3.8)   \<.0001
  Secondary or more                                        7.8 (4.6--13.2)   \<.0001   4.4 (2.2--8.9)   \<.0001   5.1 (4.1--6.4)   \<.0001   3.9 (2.9--5.3)   \<.0001
  **Wealth Index**                                                                                                                                           
  Lowest fourth                                                                          Reference                  Reference                                
  Highest                                                  2.7 (2.3--3.2)    \<.0001   1.8 (1.3--2.5)   0.0006    2.3 (2.0--2.7)   \<.0001                   
  **Ever pregnant**                                                                                                                                          
  No                                                                                                                Reference                  Reference     
  Yes                                                                                                             1.3 (1.1--1.5)   0.0101    3.0 (2.2--3.9)   \<.0001
  **Currently pregnant**                                                                                                                                     
  No                                                                                                                Reference                                
  Yes                                                                                                             1.6 (1.3--2.0)   \<.0001                   
  **HSV-2 infection**                                                                                                                                        
  No                                                          Reference                                             Reference                                
  Yes                                                      1.2 (1.1--1.4)    0.0054                               0.8 (0.7--0.9)   0.0005                    
  **Perceived HIV risk**                                                                                                                                     
  None                                                                                                              Reference                  Reference     
  Low                                                                                                             0.8 (0.7--1.0)   0.0317    0.7 (0.6--0.9)   0.0035
  Moderate                                                                                                        0.8 (0.6--1.0)   0.0151    0.7 (0.6--0.9)   0.0007
  Great                                                                                                           0.9 (0.7--1.1)   0.3454    0.9 (0.7--1.1)   0.2802
  **Lifetime sexual partners**                                                                                                                               
  1                                                           Reference                                             Reference                                
  2--3                                                     1.2 (1.0--1.6)    0.0683                               1.2 (1.0--1.3)   0.0121                    
  4 or more                                                1.2 (1.0--1.6)    0.0836                               0.7 (0.5--1.0)   0.0498                    
  **Condom use at last sex**                                                                                                                                 
  No                                                          Reference                  Reference                  Reference                                
  Yes                                                      1.9 (1.5--2.4)    \<.0001   1.6 (1.2--2.2)   0.0005    1.4 (1.1--1.9)   0.0202                    
  **Number of outpatient visits in the last 12 months**                                                                                                      
  0                                                           Reference                  Reference                  Reference                                
  1 or more                                                1.4 (1.2--1.7)    0.0003    1.9 (1.4--2.5)   \<.0001   0.9 (0.7--1.0)   0.0622                    
  **Number of hospitalizations in the last 12 months**                                                                                                       
  0                                                           Reference                                             Reference                  Reference     
  1 or more                                                2.2 (1.2--3.7)    0.0059                               2.3 (1.6--3.2)   \<.0001   2.4 (1.6--3.7)   \<.0001

Table includes all variables of which at least one category was significantly associated with ever testing for HIV in the bivariate analysis (p\<0.01).

OR = odds ratio, CI = confidence interval.

AOR = adjusted odds ratio.

Awareness of HIV status and testing history among HIV-infected persons {#s3b}
----------------------------------------------------------------------

Among all laboratory-confirmed HIV-infected persons in KAIS 2007, 56.0% (95% CI 51.9--60.0) had never been tested, 27.6% (95% CI 24.3--31.0) of HIV-infected persons reported not to be infected based on their last HIV test, and 16.4% (95% CI 13.2--19.6) reported being infected based on the results of their last HIV test. HIV-infected women (31.4%, 95% CI 27.5--35.4) were significantly more likely than men (19.5%, 95% CI 14.6--24.4, p\<0.0001) to self-report negative based on their last test result. In total, 83.6% (95% CI 76.2--91.0) of HIV-infected adults aged 15--64 years were unaware of their HIV infection ([Figure 1](#pone-0036797-g001){ref-type="fig"}). Based on these findings, in 2007, an estimated 428,000 (95% CI 371,000--486,000) HIV-infected men and 697,000 (95% CI 626,000--768,000) HIV-infected women nationwide were unaware of their HIV status.

![Awareness of HIV status and testing history among HIV-infected persons, Kenya AIDS Indicator Survey 2007.](pone.0036797.g001){#pone-0036797-g001}

Among laboratory-confirmed HIV-infected persons who reported that they had received a negative HIV test before KAIS 2007, 56.8% (95% CI 50.3--63.3) reported that their last HIV test was performed over 12 months prior to the survey, suggesting that these persons may have been exposed and infected since their last negative test. In addition, the median CD4 cell count was significantly higher in this group (595.0 cells/µL) suggesting possible recent infection, as compared to HIV-infected respondents who also reported that they were positive (412.0 cells/µL, p\<0.0001).

Missed opportunities for HIV testing {#s3c}
------------------------------------

HIV-infected, undiagnosed women who had never been tested for HIV had the highest proportion of missed testing opportunities during an ANC visit in the 12 months before the survey (39.1%, 95% CI 34.5--43.6) ([Figure 2](#pone-0036797-g002){ref-type="fig"}). In 2007, 23.2% (95% CI 17.2--29.2) of men and 45.5% (95% CI 39.7--51.4) of women had at least one missed opportunity for testing during an inpatient, outpatient or ANC visit. Overall, 87.8% (95% CI 83.8--92.0) of men and 89.4% (95% CI 86.2--92.5) of women said that they were willing to be tested at home.

![Percentages and 95% confidence intervals of missed opportunities for HIV testing among ever sexually active, HIV-infected undiagnosed persons aged 15--64 years who reported never having been tested for HIV, by gender, Kenya AIDS Indicator Survey 2007.](pone.0036797.g002){#pone-0036797-g002}

Discussion {#s4}
==========

KAIS showed that only one-quarter of ever sexually active men and less than half of ever sexually active women aged 15--64 years in Kenya in 2007 had been tested for HIV. Furthermore, more than 80% of HIV-infected adults aged 15--64 years were unaware of their HIV infection, and among those, one-third reported being uninfected but had a laboratory-confirmed positive HIV test. Time since last HIV test and higher CD4 counts suggests that many of these had sero-converted since their last HIV test.

Considering that in 2003, only 15% of all Kenyans aged 15--49 years had ever been tested (compared to 37% of that age group in KAIS), Kenya made substantial progress in expanding testing [@pone.0036797-Marum1], [@pone.0036797-CBS1]. However, overall testing coverage in 2007 remained far below Kenya\'s national goal of testing 80% of all adolescents and adults [@pone.0036797-NASCOP2], and gender difference in testing rates demonstrated a need for special efforts to bring HIV testing to men. Higher testing rates in women of reproductive age and the finding that half of these women reported that they their last HIV test was during antenatal care confirmed the importance of ANC services for HIV testing in women but also raised the question of sufficient access to HIV testing for women who do not get pregnant and older women who are less likely to get HIV tested during ANC. In addition, the large proportion of people with HIV infection reporting a previously negative HIV test indicates ongoing incident infection and the need for more frequent HIV testing than once in a lifetime.

Testing rates for both men and women were higher in urban areas (highest in the capital Nairobi), in better-educated and wealthier persons, and in persons who had contact with health facilities. In multivariable analyses, variables that were independently associated with ever HIV testing for both men and women included age, province, education and contact to health services (outpatient visits in men, hospitalizations in women). In men only, wealth index and condom use at last sex were independently associated with ever HIV testing. In women only, marital status, ever having been pregnant, and perceived HIV risk were independently associated with ever HIV testing. The considerably lower odds for ever testing in women aged 35 years and older compared to men of that age confirmed that women are testing at younger age, most likely driven by ANC services during pregnancy. All provinces with significant AOR were negatively associated with ever HIV testing when compared to Nairobi. This included North-Eastern, the province with limited need for HIV testing, given a HIV prevalence of \<1%, and Nyanza with a 40% lower odds for ever HIV testing in women yet an HIV prevalence in women of 17% compared to 10% in Nairobi. Nyanza is a mostly rural province on the shore of Lake Victoria with the highest rates for HIV in the country, at least partially due to a low prevalence of male circumcision, while North Eastern province is less populated and ethnic groups in this area traditionally circumcise. Independent associations with ever HIV testing of both education and wealth (men only) in our study highlight linkages between HIV infection, access to services, and socio-economic status [@pone.0036797-Fox1]. The main reason for not testing for HIV among those never previously tested was low perception of risk, which has been also reported from Uganda [@pone.0036797-Nakanjako1].

We found that considerable opportunities for testing were missed during general or pregnancy-specific contacts with health facilities. Our study suggests that more than 90% of all persons in Kenya with undiagnosed HIV infection who had never been tested could potentially be identified through a combination of provider-initiated testing and door-to-door testing in high prevalence provinces. However, coverage of door-to-door testing can decrease when family members cannot be reached at home [@pone.0036797-Were1].

The 2008 National Guidelines for HIV Testing and Counselling in Kenya promote a diversified approach to reduce the number of missed opportunities for providing HTC including client-initiated, provider-initiated, self-testing, home-based testing and mass HIV testing campaigns [@pone.0036797-NASCOP2]. The guidelines call for integration of HTC into other health services to allow for early detection and better health care for persons living with HIV [@pone.0036797-NASCOP2]. Our findings show that targeting sexually active men in general, sexually active non-pregnant and older women (e.g. ≥35 years), and rural and disadvantaged populations should be a priority for prevention efforts, as well as increasing general knowledge about HIV risks in a country with a prevalence of 7%. Standardized quality-control measures for HIV testing, partner testing and mutual disclosure of testing results are additional programmatic implications.

In times of increasing restrictions of funding, national strategies need to consider the most cost-efficient interventions. Menzies and colleagues estimated costs and effectiveness of four HTC strategies in Uganda in 2003--2005 [@pone.0036797-Menzies1]. Door-to-door HCT had the lowest cost per client tested (\$8.29) and per client who tested for the first time (\$9.21) compared to costs of \$11.68 and \$14.73, respectively, during hospital-based HCT. However, cost per HIV-positive individual identified was considerably higher for door-to-door HCT (\$163.93) than for hospital-based HCT (\$43.10). Door-to-door HCT was able to reach more clients as couples (21.6%) than hospital-based HCT (3.2%). Although these results may not be entirely transferable to Kenya, this study confirmed that a mixture of different types of HTC facilities will allow contributing to Kenya\'s national targets of achieving 80% of the sexually active population to know their HIV status [@pone.0036797-NASCOP2], maximize preventive effects that have been shown to be strongest among HIV-positive clients and discordant couples [@pone.0036797-Denison1], and identify as many persons as possible living with HIV but do not know their status. Further operational research is needed to determine the ideal mixture of services for a country like Kenya and the frequency of repeat testing needed for specific risk populations and in high HIV prevalence areas to identify persons with recent infection early and enroll them into care and treatment programmes. Home-based testing was acceptable to over 80% of persons aged 15--64 years in KAIS 2007 and may help achieve the national testing goal.

Program and survey data in Kenya suggest that testing coverage has continued to increase since KAIS. In 2008--9 [@pone.0036797-KNBS2], 40% of men and 57% of women aged 15--49 years in Kenya had been tested for HIV and had received results at least once in their lifetime (up from 26% and 45% for age 15--49 years, respectively, in KAIS 2007). Nevertheless, given persistent incidence [@pone.0036797-Kim1], on-going provision of testing will be critical for Kenya\'s HIV prevention, care and treatment efforts. While testing rates continue to increase in the country and this may place Kenya more towards the higher end of testing rates in sub-Saharan Africa [@pone.0036797-WHOUNAIDS1], consolidated efforts are needed to reach Kenya\'s national goal and allow all HIV-infected persons access to life saving treatment. Similar proportions of persons unaware of their HIV status as in our study may be found in other countries in Sub-Saharan Africa with a generalized HIV epidemic similar to Kenya\'s, indicating the need to include both laboratory testing results for HIV and interview data on prior testing history and current HIV status in population-based HIV surveys.

Our study had several limitations. Cross-sectional surveys do not allow for determination of the sequence of events in time. KAIS was not designed to assess HIV testing among high-risk populations, such as sex workers, men who have sex with men, or intravenous drug users (Kenya has increased surveillance efforts for these populations since 2010). Some data were not available from the study, e.g., whether respondents had not tested for HIV because no transport was available to reach a testing site or they were not able to pay for the transport, or whether they had tested as a couple. There is no generally accepted definition of a high HIV prevalence area; therefore, missed opportunities were reported across Kenya without excluding provinces with relatively low prevalence such as North-Eastern. High rates of undiagnosed infection suggest limited coverage of testing services and relatively high incidence; however, they may also partially reflect reporting bias due to misunderstanding of prior results, denial, misreporting, or false-negative test results. Finally, Kenya\'s population structure with over 40 ethnic groups of considerable cultural differences may have resulted in some differences in self-reporting. The example of reporting bias of HIV results was discussed above. In general, the direction and magnitude of any potential reporting bias is unknown.

In spite of these limitations, by including for the first time questions on HIV status and CD4 count testing among HIV-infected persons, Kenya\'s nationally representative HIV survey helped inform HIV program planning with unprecedented detail. Our findings illuminated both the high rates of undiagnosed infection throughout Kenya and the clear opportunities for expanding testing coverage to meet the national and 2008 United Nations goals of universal access to HIV prevention, treatment, care and support [@pone.0036797-WHOUNAIDS2]. Knowledge of HIV status could help protect millions of people from transmitting HIV unknowingly, from suffering unnecessarily from opportunistic infections, and from dying prematurely with no access to treatment. Three decades into an epidemic, which has already claimed more than an estimated 15 million lives in Africa alone [@pone.0036797-UNAIDS1], the urgency of universal testing access could not be clearer.
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